VARIABILITY IN PRODUCTION and IMMUNOREACTIVITY OF IN-VITRO SECRETED HUMAN THYROGLOBULIN
- 1 December 1987
- journal article
- research article
- Published by Wiley in Clinical Endocrinology
- Vol. 27 (6) , 691-701
- https://doi.org/10.1111/j.1365-2265.1987.tb02953.x
Abstract
We examined basal and bTSH-stimulated human thyroglobulin (hTg) secretion by autologous normal and abnormal (benign and malignant) human thyroid cell monolayers. Basal and bTSH-stimulated hTg secretion was highly variable and ranged from 50-700 ng/ml/105 cells over a 6 day period. All normal and benign ''non-functioning'' adenoma cells demonstrated a dose and time related stimulation of hTg secretion in response to bTSH. Comparison of hTG secretion by autologous normal and abnormal cells showed that in six of eight pairs, the normal thyroid cells had a greater output of hTg than the benign adenoma cells in contrast to our previous studies using non-autologous cells. Malignant thyroid cell hTg production was less predictable than that obtained with normal and benign thyroid cells varying from absent to normal responses to bTSH. Characterization studies of the secreted hTg showed no difference between normal, benign and malignant thyroid cell hTg with reference to molecular weight. However, hTg secreted in vitro was non-iodinated and had a marked reduction (up to 200-fold) in immunoreactivity assessed by both polyclonal and monoclonal antibodies to hTg when compared to hTg standard prepared from intact thyroid tissues (which had 4.58 .mu.g iodine/mg). This reduction in hTg immunoreactivity was greatest for hTg secreted by malignant thyroid cells. These data demonstrate the wide variability in the hTg secretory capacity of human thyroid cell monolayers and indicate, when compared to autologous normal cells, that abnormal human thyroid epithelial cells may be relatively deficient in their ability to secrete hTg in vitro. There were also qualitative differences in the immunoreactivity, and iodine content, of in-vitro secreted hTg. These observations suggest that there may be much greater heterogeneity in hTg secreted in vitro than previously realized, perhaps secondary to differences in iodine content and/or degree of glycosylation.This publication has 13 references indexed in Scilit:
- Resistance of experimental autoimmune thyroiditis induced by physiologic manipulation of thyroglobulin levelClinical Immunology and Immunopathology, 1987
- TSH RECEPTOR ANTIBODY INDUCTION OF THYROGLOBULIN RELEASE FROM HUMAN THYROID CELL MONOLAYERSClinical Endocrinology, 1986
- The Effect of Iodide Ingestion on the Development of Spontaneous Lymphocytic Thyroiditis in the Diabetes-Prone BB/W Rat*Endocrinology, 1986
- SHORT‐ AND LONG‐TERM EVALUATION OF NORMAL AND ABNORMAL HUMAN THYROID CELLS IN MONOLAYER CULTUREClinical Endocrinology, 1985
- Receptors for thyroid-stimulating hormone in normal and pathological human thyroid tissuesJournal of Endocrinology, 1984
- THYROGLOBULIN SECRETION BY HUMAN THYROID CELLS AFTER MONOLAYER CULTURE–COMPARISON OF NORMAL AND ADENOMATOUS CELLSClinical Endocrinology, 1984
- Antigen-specific B-cell function in human autoimmune thyroiditisJournal of Clinical Immunology, 1983
- Control of Thyroglobulin Synthesis and SecretionNew England Journal of Medicine, 1979
- THYROGLOBULIN OF VARYING MOLECULAR SIZES WITH DIFFERENT DISAPPEARANCE RATES IN PLASMA FOLLOWING SUBTOTAL THYROIDECTOMYClinical Endocrinology, 1978
- Radioimmunoassay for Measurement of Thyroglobulin in Human SerumJournal of Clinical Investigation, 1973